Judith J W van Beek1, Erwin E H van Wegen, Stephan Bohlhalter, Tim Vanbellingen. 1. Neurocenter, Luzerner Kantonsspital, Lucerne, Switzerland (J.J.W.v.B., S.B., T.V.); Department of Rehabilitation Medicine, Amsterdam Movement Sciences, Amsterdam Neurosciences, Amsterdam UMC, Section VUmc, Amsterdam, the Netherlands (E.E.H.v.W.); and Gerontechnology and Rehabilitation Group, University of Bern, Switzerland (T.V.).
Abstract
BACKGROUND AND PURPOSE: Many individuals with Parkinson disease (PD) suffer from impaired dexterity, which impacts activities of daily living and quality of life. Exergaming, video game-based training with augmented virtual reality, may have value for improving function. The aim of the present pilot study was to comprehensively evaluate the feasibility of a dexterity training program using exergaming, in individuals with PD. METHODS:Ten participants with PD (aged between 55 and 75 years, Hoehn and Yahr stages II-IV) trained over a period of 4 weeks, twice a week for 30 minutes. Baseline (T0) and postintervention (T1) assessments were done. Primary outcomes with respect to feasibility were the adherence rate, open-end questions, the level of participation (Pittsburgh Rehabilitation Participation Scale), and the usability (System Usability Scale). Dexterous function was measured with the Nine-Hole Peg Test and the Dexterity Questionnaire-24. Upper limb motor impairment was assessed by a modified version of the Movement Disorders Society Unified Parkinson's Disease Rating Scale III. Finally, quality of life was assessed by the 39-item Parkinson's Disease Questionnaire (PDQ-39). RESULTS:Adherence rate was 99%, motivation increased significantly from 3.9 to 4.8 (Pittsburgh Rehabilitation Participation Scale, P = 0.03), and system usability of the exergaming system was acceptable to very good. Regarding potential efficacy, participants with impaired dexterity at T0 significantly improved in the Nine-Hole Peg Test and the PDQ-39. DISCUSSIONS AND CONCLUSIONS: The outcomes of this pilot study suggest that exergaming is feasible and has potential to improve dexterity in individuals with PD. Its efficacy should be investigated in a properly powered randomized controlled trial.Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A270).
RCT Entities:
BACKGROUND AND PURPOSE: Many individuals with Parkinson disease (PD) suffer from impaired dexterity, which impacts activities of daily living and quality of life. Exergaming, video game-based training with augmented virtual reality, may have value for improving function. The aim of the present pilot study was to comprehensively evaluate the feasibility of a dexterity training program using exergaming, in individuals with PD. METHODS: Ten participants with PD (aged between 55 and 75 years, Hoehn and Yahr stages II-IV) trained over a period of 4 weeks, twice a week for 30 minutes. Baseline (T0) and postintervention (T1) assessments were done. Primary outcomes with respect to feasibility were the adherence rate, open-end questions, the level of participation (Pittsburgh Rehabilitation Participation Scale), and the usability (System Usability Scale). Dexterous function was measured with the Nine-Hole Peg Test and the Dexterity Questionnaire-24. Upper limb motor impairment was assessed by a modified version of the Movement Disorders Society Unified Parkinson's Disease Rating Scale III. Finally, quality of life was assessed by the 39-item Parkinson's Disease Questionnaire (PDQ-39). RESULTS: Adherence rate was 99%, motivation increased significantly from 3.9 to 4.8 (Pittsburgh Rehabilitation Participation Scale, P = 0.03), and system usability of the exergaming system was acceptable to very good. Regarding potential efficacy, participants with impaired dexterity at T0 significantly improved in the Nine-Hole Peg Test and the PDQ-39. DISCUSSIONS AND CONCLUSIONS: The outcomes of this pilot study suggest that exergaming is feasible and has potential to improve dexterity in individuals with PD. Its efficacy should be investigated in a properly powered randomized controlled trial.Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A270).
Authors: Yusha Liu; Rafael M L Silva; Jeffrey B Friedrich; Dennis S Kao; Pierre D Mourad; Aaron E Bunnell Journal: Plast Reconstr Surg Date: 2022-05-10 Impact factor: 5.169
Authors: Lee-Kuen Chua; Yu-Chen Chung; David Bellard; Laura Swan; Nicole Gobreial; Amanda Romano; Ryan Glatt; Michael A Bonaguidi; Darrin J Lee; Yi Jin; Charles Y Liu; Beth E Fisher Journal: Int J Environ Res Public Health Date: 2021-11-25 Impact factor: 3.390
Authors: Francesco Zanatta; Anna Giardini; Antonia Pierobon; Marco D'Addario; Patrizia Steca Journal: BMC Health Serv Res Date: 2022-04-20 Impact factor: 2.908
Authors: Judith Jantine Willemijn van Beek; Erwin Everardus Henri van Wegen; Marc Berend Rietberg; Thomas Nyffeler; Stephan Bohlhalter; Christian Philipp Kamm; Tobias Nef; Tim Vanbellingen Journal: JMIR Mhealth Uhealth Date: 2020-06-09 Impact factor: 4.773